Risk of incident venous thromboembolism in patients with atopic dermatitis: systematic analysis of the literature and meta-analysis Yifei WangZhiqiang ChenChen Shen ReviewPaper 06 September 2024
Prognostic outcome of intravenous thrombolysis in elderly patients aged ≥ 60 years with acute ischemic stroke by ASTRAL and THRIVE scales Yani FanGuoyan ShiLili Chen OriginalPaper 06 September 2024
Interindividual variability in platelet reactivity among individuals with or without antiplatelet therapy: results from a large tertiary care hospital Mattia GalliSergio TerracinaFabio M. Pulcinelli OriginalPaper Open access 06 September 2024
Heparin-like effect of a dual antiplatelet and anticoagulant (APAC) agent on red blood cell deformability and aggregation in an experimental model Adam Attila MatraiAdam VargaAdam Deak OriginalPaper Open access 04 September 2024
RNAi targeting LMAN1-MCFD2 complex promotes anticoagulation in mice Siqian MaBoyan LiuMiao Jiang OriginalPaper Open access 02 September 2024
E-Cigarettes induce expression of procoagulant tissue factor in cultivated human endothelial cells Plinio CirilloMariarosaria MorelloGiovanni Cimmino OriginalPaper 29 August 2024
Finding individualised treatment in obese needing enoxaparin (FIT ONE): a multicentre study of therapeutic enoxaparin and the role of anti-factor Xa monitoring Marcelle AppayJustine LaiJan-Willem Alffenaar OriginalPaper Open access 27 August 2024
The potential role of factor XI inhibitors in managing long COVID Chia Siang KowDinesh Sangarran RamachandramKaeshaelya Thiruchelvam Letter to the Editor 26 August 2024
Mortality rate and factors associated with in-hospital mortality in patients hospitalized with pulmonary embolism in Germany Karel KostevOliver LaduchMark Luedde OriginalPaper 23 August 2024
Ghrelin may protect against vascular endothelial injury in Acute traumatic coagulopathy by mediating the RhoA/ROCK/MLC2 pathway Chengjian HeXiaojing SongRongjun Xie OriginalPaper Open access 23 August 2024
Intravenous thrombolysis versus dual antiplatelet therapy in minor ischemic stroke within the thrombolytic window (TAMIS): a multicenter cohort study Dan WangQianru WenHeng Meng OriginalPaper 23 August 2024
The COVID-19 thrombus: distinguishing pathological, mechanistic, and phenotypic features and management Richard C. BeckerUdaya S. TantryPaul A. Gurbel ReviewPaper Open access 23 August 2024
COVID-19 vaccination and short-term anti-coagulation levels in warfarin treatment: correspondence Hinpetch DaungsupawongViroj Wiwanitkit Letter to the Editor 16 August 2024
Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in low-weight patients with atrial fibrillation Kuan-Hsuan ChenYeh-Yun HsuYuh-Lih Chang OriginalPaper Open access 14 August 2024
Clot lysis time and thrombin generation in patients undergoing transcatheter aortic valve implantation Aleksander SiniarskiAleksandra GąseckaGrzegorz Gajos OriginalPaper Open access 08 August 2024
New interest in fibrinogen as an ischemic risk factor Udaya S. TantryKevin P. BlidenPaul A. Gurbel BriefCommunication 07 August 2024
Impact of thyroid function on coagulation and venous thromboembolism: a two-sample mendelian randomization study Xiaoqian LiPing LinZongan Liang OriginalPaper 07 August 2024
The use of non-vitamin K antagonist oral anticoagulants in chronic thromboembolic pulmonary hypertension: an updated meta-analysis Dexi WuHuiling LiangWengen Zhu ReviewPaper 30 July 2024
Direct oral anticoagulants in embolic stroke of undetermined source: an updated meta-analysis Gabriel MarinheiroBeatriz AraújoJoão Paulo Mota Telles ReviewPaper 29 July 2024
Factor XIa inhibition as a therapeutic strategy for atherothrombosis Eric BaileyRenato D. LopesSunil V. Rao ReviewPaper 29 July 2024
Comparative analysis of COVID-19-associated venous thromboembolism outcomes: evolution from 2020 to 2021–2022 Francisco Galeano-VallePablo Demelo-Rodríguezthe RIETE Investigators OriginalPaper 29 July 2024
Growth differentiation factor-15 predicts all-cause death and major adverse cardiovascular events in patients with coronary heart disease: a prospective cohort study Lyu LyuCui XvHongbin Liu OriginalPaper 28 July 2024
Enhanced thrombin generation induced by extracellular vesicles from severe COVID−19 cases Bárbara Gomes BarionRenata de Freitas SaitoFernanda Andrade Orsi BriefCommunication 27 July 2024
Machine learning-based prediction model of lower extremity deep vein thrombosis after stroke Lingling LiuLiping LiGuangxu Xu OriginalPaper 27 July 2024
Identifying the vulnerable patient: pericoronary Adipose tissue attenuation on computed tomography Udaya S. TantryLekshmi Narayan RaghavakurupPaul A. Gurbel Editorial 16 July 2024 Pages: 877 - 879
Risks of major bleeding and venous thromboembolism in patients undergoing total hip or total knee arthroplasty using therapeutic dosages of DOACs Mark J. R. SmeetsEskild Bendix KristiansenAlma Becic Pedersen BriefCommunication 16 July 2024
The journal of thrombosis and thrombolysis: commemorating the written word in science and medicine: three decades and counting Richard C. Becker Editorial 09 July 2024
SARS-CoV-2 spike protein potentiates platelet aggregation via upregulating integrin αIIbβ3 outside-in signaling pathway Ruijie WangZezhong TianYan Yang BriefCommunication 09 July 2024
Risk of venous thromboembolism in relation to high physical activity level in men over 27 year follow up P. WändellM. A. EnarssonA. C. Carlsson OriginalPaper Open access 09 July 2024
Accuracy of the COMPASS-CAT thrombosis risk assessment scale in predicting venous thromboembolism in cancer patients: a meta-analysis Wei ZhouShujuan ChenShirong Fang OriginalPaper 09 July 2024
Clinical outcomes of patients with atrial fibrillation in relation to multimorbidity status changes over time and the impact of ABC pathway compliance: a nationwide cohort study Rungroj KrittayaphongArjbordin WinijkulGregory Y. H. Lip OriginalPaper 09 July 2024
Reduced protein carbonylation on hormone therapy is associated with improved fibrinolysis in postmenopausal women: the impact of PAI-1 and TAFI activity Magdalena PirógMichał ZąbczykAnetta Undas OriginalPaper Open access 09 July 2024
Initial hemodynamic status and Acute Mortality in Cancer patients with Acute Pulmonary Embolism: from the COMMAND VTE Registry Wei XiongYugo YamashitaThe COMMAND VTE Registry Investigators OriginalPaper 09 July 2024
Elevated plasma protein carbonylation increases the risk of ischemic cerebrovascular events in patients with atrial fibrillation: association with a prothrombotic state Karol NowakMichal ZabczykAnetta Undas OriginalPaper Open access 04 July 2024
Assessment of associations between neutrophil extracellular trap biomarkers in blood and thrombi in acute ischemic stroke patients Tristan BaumannNicole de BuhrRamona Schuppner OriginalPaper Open access 09 June 2024 Pages: 936 - 946
ET1 acts as a potential plasma biomarker and therapeutic target in deep venous thrombosis rat model Zhanqi WangZhangmin WuZhong Chen OriginalPaper Open access 02 June 2024 Pages: 1067 - 1075
Effect of Ultrasound on Thrombus debris during Sonothrombolysis in a Microfluidic device Xiaobing ZhengYunfan PanShuguang Zhang OriginalPaper 02 June 2024 Pages: 1056 - 1066
Cerebral venous sinus thrombosis associated with cancer: analysis of the ACTION-CVT study Maria Cristina VedovatiLiqi ShuMaurizio Paciaroni OriginalPaper Open access 02 June 2024 Pages: 1008 - 1017
Poly (ADP-ribose) Polymerase-1 modulations in the genesis of thrombosis Raishal SafdarAastha MishraMohammad Zahid Ashraf ReviewPaper 24 May 2024 Pages: 743 - 753
NEUT-RI, a surrogate marker of NETosis is lower in patients with strong IgM antiphospholipid antibodies Sylvie BouvierMathieu FortierJean-Christophe Gris BriefCommunication 18 May 2024 Pages: 1051 - 1055
Predictors of bleeding and thrombotic events among patients admitted to the hospital with COVID-19 and elevated D-dimer: insights from the ACTION randomized clinical trial Pedro Gabriel Melo de Barros e SilvaRemo H. M. Furtadoon behalf of the ACTION Coalition COVID-19 Brazil IV Investigators OriginalPaper 18 May 2024 Pages: 1031 - 1039
Optimizing resource allocation: Cost-effectiveness of specified D-dimer cut-offs in cancer patients with suspected venous thromboembolism Teodora BiciuscaLeon D. GruenewaldVitali Koch OriginalPaper Open access 18 May 2024 Pages: 996 - 1007
Patent foramen ovale closure in ischemic stroke patients with and without thrombophilia: a systematic review and meta-analyses Xue Yang LimNicholas LX GaoBenjamin YQ Tan ReviewPaper 18 May 2024 Pages: 947 - 958
Optimal hemodynamic parameters for risk stratification in acute pulmonary embolism patients Marco ZuinStanislav HenkinGregory Piazza OriginalPaper 18 May 2024 Pages: 918 - 928
Statins use and recurrent venous thromboembolism in the direct oral anticoagulant era: insight from the COMMAND VTE Registry-2 Hiroshi MabuchiRyusuke NishikawaTakeshi Kimura OriginalPaper 18 May 2024 Pages: 907 - 917
Factor XI as a new target for prevention of thromboembolism in cardiovascular disease: a meta-analysis of randomized controlled trials Ahmed E. AliMohamed K. AwadMuhammad S. Mazroua OriginalPaper 18 May 2024
Cancer progression and tumor hypercoagulability: a platelet perspective Yifan ZhangJingtong ZengZuoqing Song ReviewPaper 17 May 2024 Pages: 959 - 972
Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register study Marie LinderAnders EkbomDiego Hernan Giunta OriginalPaper Open access 12 May 2024 Pages: 973 - 983
Differences in quality of anticoagulation care delivery according to ethnoracial group in the United States: A scoping review Sara R. VazquezNaomi Y. YatesMary M. McFarland OriginalPaper Open access 11 May 2024 Pages: 1076 - 1091
Protein C and S activities in COVID-19: A systematic review and meta-analysis Zahra KhoshnegahPayam SiyadatHassan Mansouritorghabeh ReviewPaper 09 May 2024 Pages: 1018 - 1030